Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The approval enables the use of inavolisib in patients whose cancer has recurred...
The formulation will serve as a new administration route. Eisai’s application is...
The company will manufacture the product at its biotechnology facility in Pune, ...
This submission is the initial application for VIZZ under the exclusive licence ...
The partnership brings together Citizen Health’s AI-based patient insights and a...
The designation, which covers serious and life-threatening diseases affecting th...
This applies to patients previously treated with a covalent Bruton tyrosine kina...
With this collaboration, drug developers get access to the technology, which is ...
The licensing agreement covers Thailand, Singapore, the Philippines and Indonesi...
Companies outline roles in manufacturing, commercialisation and distribution Th...
Medley expands nutraceutical portfolio with fortified biscuit offering The post...
Approval covers 0.25 mg, 1 mg and 2 mg strengths for multiple sclerosis treatm...
“Evolution of Escherichia coli Expression System in Producing Antibody Recombina...
ARVYS Proteins Inc. provides a full spectrum of protein biochemistry services – ...
ARVYS Proteins Inc. provides a full spectrum of protein biochemistry services – ...
ARVYS Proteins Inc. provides a full spectrum of protein biochemistry services – ...